Home ›
Companies in Liquidation ›
Caldan Therapeutics Limited Is Caldan Therapeutics Limited in creditors' voluntary liquidation?
Last verified 26 May 2026
Yes, Caldan Therapeutics Limited (company number SC515558) entered creditors' voluntary liquidation on 17 September 2024, by its creditors.
Do you deal with companies like Caldan Therapeutics Limited? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Caldan Therapeutics Limited is now in creditors' voluntary liquidation. Below are the key dates, the directors, the public-record timeline that led here, and what the liquidation means if you are a creditor, employee, customer or supplier.
Company at a glance
| Status | In Creditors' Voluntary Liquidation |
|---|
| Company number | SC515558 |
|---|
| Incorporated | 14 September 2015 (11 years old) |
|---|
| Registered office | 7 St James Terrace, Kilmacolm, PA13 4HB |
|---|
| Nature of business (SIC) | 72110: Research and experimental development on biotechnology |
|---|
| Date entered creditors' voluntary liquidation | 17 September 2024 |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Caldan Therapeutics Limited is a UK limited company based in Kilmacolm, incorporated in 2015 and 9 years old when the liquidator was appointed. Its registered activity is research and experimental development on biotechnology (SIC 72110). There have been 11 director appointments since incorporation, of which 5 were on the board when the liquidator was appointed, alongside 1 person with significant control. 2 charges have been registered against the company, all of which are recorded as satisfied.
Directors
11 people have been appointed as directors of Caldan Therapeutics Limited.
DirectorStatusAppointedResigned
+5 former directors · resigned 2019 to 2023
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Epidarex Capital Ii Lp
corporate entity person with significant control
Ownership of shares 25-50% as firmVoting rights 25-50% as firm
2 ceased controls
- Scottish Enterprise · ceased 6 Apr 2016
- Epidarex Capital Partners Limited · ceased 6 Apr 2016
Charges register
Secured creditors and encumbrances against the company. 0 outstanding · 2 satisfied.
Status · Creditor · Type · Dates
SatisfiedHsbc Innovation Banking
A registered charge · Created 22 Aug 2023 · Satisfied 26 Feb 2025
SatisfiedSilicon Valley Bank
A registered charge · Created 25 Aug 2016 · Satisfied 31 Aug 2023
What happened
EventDateType
Final account prior to dissolution in CVL30 April 2026LIQ14(Scot)
Satisfaction of charge SC5155580002 in full26 February 2025MR04 Registered office address changed from 7-11 Melville Street Edinburgh EH3 7PE to 7 st James Terrace Lochwinnoch Road Kilmacolm PA13 4HB on 2024-11-077 November 2024AD01 Creditors' voluntary liquidationStatus17 September 2024
+68 earlier events · 2015 to 2024
Confirmation statement made on 2024-06-12 with updates12 June 2024CS01 Full accounts made up to 2023-09-309 January 2024AA Appointment of Dr Lori Krim Gough as a director on 2023-11-1522 November 2023AP01 Termination of appointment of Henning Klaus-Willi Christian Steinhagen as a director on 2023-11-1522 November 2023TM01 Termination of appointment of Linda Anne Dugdale-Bradley as a director on 2023-08-314 September 2023TM01 Satisfaction of charge SC5155580001 in full31 August 2023MR04 Registration of charge SC5155580002, created on 2023-08-2230 August 2023MR01 Confirmation statement made on 2023-06-12 with updates14 June 2023CS01 Statement of capital following an allotment of shares on 2023-01-1820 January 2023SH01 Statement of capital following an allotment of shares on 2023-01-1116 January 2023SH01 Full accounts made up to 2022-09-3019 December 2022AA Change of details for Epidarex Capital Ii Lp as a person with significant control on 2016-04-0617 June 2022PSC05 Confirmation statement made on 2022-06-12 with updates16 June 2022CS01 Termination of appointment of Frank Murdoch Armstrong as a director on 2022-05-3116 June 2022TM01 Statement of capital following an allotment of shares on 2022-05-1016 May 2022SH01 Accounts for a small company made up to 2021-09-307 December 2021AA Confirmation statement made on 2021-06-12 with updates15 June 2021CS01 Appointment of Dr Mary Eugenie Canning as a director on 2021-04-2227 April 2021AP01 Appointment of Dr Linda Anne Dugdale-Bradley as a director on 2021-04-2227 April 2021AP01 Termination of appointment of Michael Alexander Dalrymple as a director on 2021-03-2926 April 2021TM01 Termination of appointment of Elizabeth Ann Roper as a director on 2021-04-2226 April 2021TM01 Memorandum and Articles of Association26 February 2021MA Director's details changed for Dr Mark Anthony Payton on 2020-12-1616 December 2020CH01 Accounts for a small company made up to 2020-09-3011 December 2020AA Confirmation statement made on 2020-06-12 with updates16 June 2020CS01 Change of details for Epidarex Capital Ii Lp as a person with significant control on 2020-06-1216 June 2020PSC05 Director's details changed for Dr Elizabeth Ann Roper on 2020-06-1216 June 2020CH01 Accounts for a small company made up to 2019-09-3011 December 2019AA Statement of capital following an allotment of shares on 2019-10-0717 October 2019SH01 Statement of capital following an allotment of shares on 2019-09-181 October 2019SH01 Appointment of Dr Mark Anthony Payton as a director on 2019-07-316 August 2019AP01 Appointment of Dr Henning Klaus-Willi Christian Steinhagen as a director on 2019-07-316 August 2019AP01 Termination of appointment of Peter Michael Finan as a director on 2019-07-316 August 2019TM01 Statement of capital following an allotment of shares on 2019-06-195 July 2019SH01 Appointment of Dr Michael Alexander Dalrymple as a director on 2019-06-1927 June 2019AP01 Confirmation statement made on 2019-06-12 with updates13 June 2019CS01 Accounts for a small company made up to 2018-09-309 April 2019AA Cessation of Scottish Enterprise as a person with significant control on 2016-04-066 December 2018PSC07 Cessation of Epidarex Capital Partners Limited as a person with significant control on 2016-04-066 December 2018PSC07 Statement of capital following an allotment of shares on 2018-07-2623 August 2018SH01 Confirmation statement made on 2018-06-12 with updates15 June 2018CS01 Full accounts made up to 2017-09-303 January 2018AA Director's details changed for Mr Frank Murdoch Armstrong on 2017-12-1415 December 2017CH01 Statement of capital following an allotment of shares on 2017-10-051 November 2017SH01 Director's details changed for Mr Trond Ulven on 2017-10-1717 October 2017CH01 Director's details changed for Dr Peter Michael Finan on 2017-10-1717 October 2017CH01 Director's details changed for Dr Elizabeth Ann Roper on 2017-10-1717 October 2017CH01 Statement of capital following an allotment of shares on 2017-06-2311 July 2017SH01 Confirmation statement made on 2017-06-12 with updates12 June 2017CS01 Full accounts made up to 2016-09-3014 February 2017AA Statement of capital following an allotment of shares on 2016-11-1722 November 2016SH01 Confirmation statement made on 2016-09-14 with updates22 September 2016CS01 Register(s) moved to registered inspection location Commerce House South Street Elgin Moray IV30 1JE22 September 2016AD03 Register inspection address has been changed to Commerce House South Street Elgin Moray IV30 1JE22 September 2016AD02 Registration of charge SC5155580001, created on 2016-08-259 September 2016MR01 Registered office address changed from No.11 the Square University Avenue Glasgow G12 8QQ United Kingdom to 7-11 Melville Street Edinburgh EH3 7PE on 2016-07-088 July 2016AD01 Appointment of Mr Frank Murdoch Armstrong as a director on 2016-03-088 March 2016AP01 Director's details changed for Doctor Elizabeth Roper on 2015-11-099 November 2015CH01 Appointment of Dr Peter Michael Finan as a director on 2015-11-099 November 2015AP01 Statement of capital following an allotment of shares on 2015-10-0914 October 2015SH01 Appointment of Doctor Elizabeth Roper as a director on 2015-10-099 October 2015AP01 Incorporation14 September 2015NEWINC What this means for you
If you are a creditor
Submit your proof of debt to the liquidator. Once liquidation begins, no creditor can start or continue legal action without the court's permission. Unsecured creditors rank after secured and preferential creditors and are usually paid last, often only a portion.
Owed money by a company in liquidation →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Deposits paid are usually unsecured claims. Contracts may be terminated by the liquidator. Contact the liquidator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the liquidation began are an unsecured claim. Check whether any retention-of-title clause lets you identify and recover specific goods.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other companies in creditors' voluntary liquidation
Related guides
The bigger picture
Frequently asked questions
- Is Caldan Therapeutics Limited in creditors' voluntary liquidation?
- Yes. Caldan Therapeutics Limited (company number SC515558) entered creditors' voluntary liquidation on 17 September 2024, by its creditors.
- What does Caldan Therapeutics Limited do?
- Caldan Therapeutics Limited's registered nature of business is research and experimental development on biotechnology (SIC 72110).
- Where is Caldan Therapeutics Limited based?
- Caldan Therapeutics Limited's registered office is 7 St James Terrace, Kilmacolm, PA13 4HB. The registered office is the address held on the public register, which is not always the trading address.
- When was Caldan Therapeutics Limited founded?
- Caldan Therapeutics Limited was incorporated on 14 September 2015, 9 years before the liquidator was appointed.
- What is Caldan Therapeutics Limited's company number?
- Caldan Therapeutics Limited's registered company number is SC515558.
- Who has significant control of Caldan Therapeutics Limited?
- 1 active person with significant control over Caldan Therapeutics Limited is on the register: Epidarex Capital Ii Lp.
- What does liquidation mean for creditors of Caldan Therapeutics Limited?
- Liquidation is the formal wind-up of a company. Once it begins, the liquidator collects assets, settles claims in statutory order (secured, preferential, then unsecured) and distributes whatever remains. Unsecured creditors often recover only a portion of what they are owed, and sometimes nothing.
- How long does liquidation take?
- Most liquidations run for 12 to 24 months, longer where the company has complex assets, litigation, or ongoing trading. Annual progress reports are filed by the liquidator until the company is dissolved at the end of the process.
- Will creditors get paid in Caldan Therapeutics Limited's liquidation?
- Secured creditors are paid from the assets they hold a charge over. Preferential creditors (employee wages up to limits, pension contributions, HMRC for certain taxes) come next. Unsecured creditors share whatever remains, which may be nothing. The Statement of Affairs, when filed, sets out the liquidator's estimate at the point of appointment.
Report an error on this page·Not financial, credit or legal advice.